SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Pharmacosmos | Pharmaceuticals, Biotechnology and Life Sciences | Europe | Targets set | Medium | - | Jul 23, 2026 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year - Long-Term Status - Net-Zero Status - Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Europe Organization Type Corporate Location Denmark Company Size Medium Target Statement Near-Term Targets: Pharmacosmos commits to reduce absolute scope 1 and 2 GHG emissions 55.0% by FY2032 from a FY2022 base year.* Pharmacosmos also commits that 74.42% of its suppliers by emissions covering purchased goods and services, capital goods, upstream transportation and d… Stakeholders No stakeholders identified yet. | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.